Reclide MR 30 Tablet
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Gliclazide (30mg)
Overview Reclide MR 30 Tablet
Glyciphase XR 30mg tablets manage type 2 diabetes in adults. A sulfonylurea, it regulates blood glucose, mitigating complications such as renal impairment and vision loss. Prescription may be standalone or adjunct therapy, always taken with food, consistently at the same time daily for optimal efficacy. Dosage is individualized and subject to adjustment based on response. Continuous use is crucial; premature cessation can elevate blood sugar, increasing the risk of nephropathy, blindness, neuropathy, and limb loss. This medication complements a holistic approach encompassing diet, exercise, and weight management as directed by your physician; lifestyle significantly impacts diabetes control. Common side effects include dyspepsia and gastrointestinal discomfort; hypoglycemia (low blood sugar) is also possible. Learn to identify hypoglycemia symptoms (sweating, vertigo, cephalalgia, tremor) and implement appropriate countermeasures. Maintain regular meals and carry a rapid-acting glucose source (e.g., sweets, fruit juice). Alcohol consumption should be minimized due to its hypoglycemic effect. Weight gain may occur. Contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart, thyroid, or endocrine disorders should be disclosed to your physician before initiating treatment; pregnancy or lactation mandates medical consultation. Regular blood glucose monitoring, along with periodic blood cell and liver function tests, are essential.
Primary Ingredients of Reclide MR 30 Tablet
No text provided to rephrase.
Uses of Reclide MR 30 Tablet
Managing type 2 diabetes
Major Benefits of Reclide MR 30 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Reclide MR 30 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Reclide MR 30 Tablet:
- Hypoglycemia (low blood glucose level)
- Weight gain
- Flatulence
- Diarrhea
- Headache
- Nausea
- Dizziness
How to use Reclide MR 30 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Reclide MR 30 Tablet with a meal.
How Reclide MR 30 Tablet works:
This drug treats diabetes by stimulating pancreatic insulin secretion, thus reducing blood glucose concentrations.
SAFETY ADVICE
AlcoholUNSAFE
Combining Reclide MR 30 Tablet with alcohol is contraindicated due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Reclide MR 30 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the benefits against potential risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Breastfeeding mothers should not use Reclide MR 30 Tablets. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.
KidneySAFE IF PRESCRIBED
Reclide MR 30 Tablet is considered safe for individuals with kidney impairment, and no dosage modification is typically advised. Nevertheless, its use is prohibited in those experiencing severe kidney dysfunction.
LiverCAUTION
Patients with severe hepatic impairment should use Reclide MR 30 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Reclide MR 30 Tablet :
Should you forget a dose of Reclide MR 30 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Reclide MR 30 Tablet
| Label | Value |
|---|---|
| Chemical Category | Improved sulfonylurea |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Behavioral Class | Insulin-Stimulating Sulfonylureas |




